Prevention and treatment of brain diseases and disorders related to abnormal protein aggregation through electromagnetic field treatment
US10149982B2 · kind B2 · utility
Assignees
Inventors
Key dates
| Filing date | Dec 21, 2015 |
| Grant date | Dec 11, 2018 |
| Priority date | — |
| Expiry date | Jul 23, 2036 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61N2/02
- WIPO fieldMedical technology
- WIPO sectorInstruments
Abstract
A method of treating and preventing a neurological disorder, such as Alzheimer's disease, in a subject in need thereof by positioning an electromagnetic field emitting source proximal to the subject and exposing the subject to an electromagnetic field having a predetermined frequency (preferably ≈300-3,000 MHz) for a predetermined absorption period (preferably greater than ≈3 days). Each individual treatment (comprising exposure to the predetermined frequency for the predetermined absorption period) is continued at a predetermined schedule for a predetermined treatment period. The EMF can have a specific absorption rate up to about 8 W/kg. The methodology enhances cognition in the subject and/or treats/prevents the underlying neurological disorder or a symptom thereof.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.